← Back to Search

Prosthesis

Point Mini Device for Hand Amputation

N/A
Waitlist Available
Led By Levin Sliker, PhD
Research Sponsored by Point Designs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Partial hand loss with at least index and/or middle fingers loss at the MCP level
Intact thumb with full range of motion
Must not have
Unhealed wounds
Significant neurological deficits as determined upon clinical evaluation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (10 minutes)
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to test a new device called Point Mini by having 5 children with partial-hand upper limb loss perform different tasks. If they can complete a task, it means the device meets a user

Who is the study for?
This trial is for a small group of 5 children who have lost part of their hand, either from birth or due to an accident. The study aims to see if they can perform certain tasks using the Point Mini system.
What is being tested?
The Point Mini system is being tested in this trial. It's designed for children with partial-hand upper limb loss, and the goal is to see if it helps them complete specific tasks successfully.
What are the potential side effects?
Since this trial involves testing a device rather than a drug, traditional side effects are not applicable. However, there may be discomfort or difficulty in using the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have lost part of my hand, including at least the index or middle finger.
Select...
My thumb is fully functional.
Select...
I am between 5 and 15 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have wounds that have not healed.
Select...
I do not have major nerve or brain function issues.
Select...
My amputation site has not fully healed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (10 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (10 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
VAL-1
VAL-2
VAL-3.1
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ProsthesisExperimental Treatment1 Intervention
Patient is temporarily fit with Point Mini finger prosthetic system

Find a Location

Who is running the clinical trial?

Point DesignsLead Sponsor
6 Previous Clinical Trials
61 Total Patients Enrolled
University of Colorado, DenverOTHER
1,802 Previous Clinical Trials
2,822,107 Total Patients Enrolled
Levin Sliker, PhDPrincipal InvestigatorCEO, Point Designs
~3 spots leftby Mar 2025